RCS - Cactus Life Sciences - Cactus Life Announces Appointment of Oliver Dennis

BridgepointAnnouncement

16/04/2024 18:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240416:nRSP8524Ka&default-theme=true

RNS Number : 8524K  Cactus Life Sciences  16 April 2024

Cactus Life Sciences Announces Appointment of Oliver Dennis as Chairman to
Shape the Agency of the Future

Fishawack Health Founder's Deep History in Healthcare Communications Blends
Nicely with Global Scientific Communications Agency's Upcoming Buy-and-Build
Strategy

PRINCETON, NJ / ACCESSWIRE / April 16, 2024 / Cactus Life Sciences, a leading
global scientific communications agency that works with blue chip pharma and
biotechnology companies, announced today that Oliver Dennis has joined them as
Chairman, to work alongside Co-founder, Anurag Goel.

IMAGE: https://cdn.nwe.io/files/x/a3/94/e69f2ba80f26ba97b986c1005693.jpg
(https://cdn.nwe.io/files/x/a3/94/e69f2ba80f26ba97b986c1005693.jpg)

Cactus Life Sciences, headquartered in Princeton, New Jersey was formed in
2010 and is best known for its transformational global operating models that
provide best in class science, innovation, and efficiency. "We're delighted to
have someone with Oliver's experience of growing businesses join the team,"
said Anurag. "Cactus Life Sciences is about to undertake an exciting buy and
build strategy. And Oliver is the perfect addition with his deep history in
healthcare communications having founded Fishawack Health® (now
Avalere(®))."

During Oliver's tenure at Fishawack, he acquired 17 businesses over 13 years
including medical communications and branding agencies, as well as strategic
healthcare consultancies and market access and HEOR advisory firms. He led 4
management buy outs to take the business from a start-up to over 1400 people
across 22 offices, spanning San Diego to Singapore. Oliver will specifically
help shape the future vision for Cactus Life Sciences as the healthcare
communications agency partner of the future (strategic, agile, tech-enabled,
and outcomes focused) to take on traditional agencies which have lost agility
and identity in the pursuit of maximizing profit. He will play an active role
in driving the inorganic growth strategy for the business, while pursuing his
passion for bringing people together from different businesses and disciplines
to collaborate on better outcomes for clients, patients, and our people.

"I've been following Cactus over the last 10 years and they're a great
organization. I'm excited to be joining them. They've grown consistently and
they have the ambition to become the next generation challenger brand to the
traditional players in the market," said Oliver. "This is an opportunity to do
something with a greater focus on solving client challenges, improving health
outcomes, and nurturing our people."

"Too many companies get to a size where they lose their sense of purpose,
values, and forget about individuality. As we work toward transforming Cactus
Life Sciences into an agency of the future, we want to ensure that we do so
while ensuring that patients and our people are at the core of everything we
do," said Elvira D'souza, President of Cactus Life Sciences.

About Cactus Life Sciences (cactuslifesciences.com
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9jYWN0dXNsaWZlc2NpZW5jZXMuY29t&sig=LJ5FxeheBx07EjGURrcY5XwS__zVZUu4fELiGKbvpSSTYfp6Q6JnNZYO8ojiH003YY6mMB6q4DaiHuiAh50LgA&hit%2Csum=WyI0YTZ3dzgiLCI0YTZ3dzkiLCI0YTZ3d2EiXQ)
) Cactus Life Sciences is a medical communication company that provides
scientific strategy and content across the healthcare continuum, anywhere in
the world─with a focus on science, innovation, and efficiency. We work
alongside leading healthcare companies to establish the optimal role of
medicines and encourage positive behaviors (physician and patient) that
improve patient outcomes. CACTUS has offices in Princeton, London, Aarhus,
Singapore, Beijing, Shanghai, Seoul, Tokyo, and Mumbai.

Contact Information:

Laura Perry

Vice President of Strategy & Marketing
laura.perry@cactusglobal.com (mailto:laura.perry@cactusglobal.com)

7327121005

SOURCE: Cactus Life Sciences

 

View the original press release
(https://www.newswire.com/news/cactus-life-sciences-announces-appointment-of-oliver-dennis-as-22302477)
on newswire.com.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAIFMITMTABBFI